TLR4 and neoplasm: Anthracycline chemotherapies induce an immunogenic cell death (ICD) program in tumor cells, including the release of damage-associated molecular patterns (DAMPs), which are subsequently sensed by complementary PRRs, especially TLR4 expressed on DCs (Zitvogel et al., 2013).